HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 232 filers reported holding HORIZON PHARMA PLC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,394,000 | +35.7% | 166,217 | +0.3% | 0.05% | +14.3% |
| Q4 2018 | $3,239,000 | -0.2% | 165,734 | 0.0% | 0.04% | +35.5% |
| Q3 2018 | $3,245,000 | +18.2% | 165,734 | 0.0% | 0.03% | +14.8% |
| Q2 2018 | $2,745,000 | +16.7% | 165,734 | 0.0% | 0.03% | +12.5% |
| Q1 2018 | $2,353,000 | -8.8% | 165,734 | -6.2% | 0.02% | 0.0% |
| Q4 2017 | $2,581,000 | +15.2% | 176,748 | 0.0% | 0.02% | +33.3% |
| Q3 2017 | $2,241,000 | +4.7% | 176,748 | -2.0% | 0.02% | 0.0% |
| Q2 2017 | $2,140,000 | -22.3% | 180,275 | -3.3% | 0.02% | -25.0% |
| Q1 2017 | $2,754,000 | -7.2% | 186,354 | +1.6% | 0.02% | 0.0% |
| Q4 2016 | $2,967,000 | -17.7% | 183,383 | -7.7% | 0.02% | -14.3% |
| Q3 2016 | $3,604,000 | +159.1% | 198,762 | +135.4% | 0.03% | +133.3% |
| Q2 2016 | $1,391,000 | +139000.0% | 84,446 | +703616.7% | 0.01% | – |
| Q4 2015 | $1,000 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scale Management, LLC | 1,710,451 | $37,065,000 | 56.74% |
| Broadfin Capital, LLC | 8,131,310 | $176,205,000 | 10.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,684,801 | $253,210,000 | 10.26% |
| ATERNALIS CAPITAL LLC | 410,000 | $8,885,000 | 5.84% |
| JW Asset Management, LLC | 673,075 | $14,586,000 | 5.44% |
| NEXTHERA CAPITAL LP | 144,000 | $3,120,000 | 4.43% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 739,485 | $16,025,000 | 2.77% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,519,955 | $54,607,000 | 2.66% |
| Ratan Capital Management LP | 500,000 | $10,835,000 | 2.39% |
| TIGER MANAGEMENT L.L.C. | 823,577 | $17,847,000 | 2.30% |